Vismodegib as an adjuvant treatment for periorbital basal cell carcinoma: a case report and review of literature.
Sayena JabbehdariManasa VeluvoluTom KornhauserThomas A JenningsJohn D Pemberton
Published in: Annals of translational medicine (2024)
Neoadjuvant vismodegib, followed by surgery excision, such as Mohs micrographic surgery, has shown a promising clinical and aesthetic outcome in the treatment of periorbital BCC.